Instructions for use of Bengalantamine

Bengalantamine is a prescription drug specially designed for patients with mild to moderate dementia from Alzheimer's disease (AD). Its treatment goal is to improve the patient's thinking ability, memory and ability to carry out daily activities. Compared with galantamine, another commonly used AD treatment drug, benzalantamine has relatively few side effects on the stomach such as nausea and vomiting while maintaining considerable efficacy, so it is favored by the medical community and patients. So, how to use benzalantamine correctly? Its usage and dosage will be introduced in detail below.

Regarding the dosage of phengalantamine, the recommended starting dose is 5 mg per time twice daily, administered orally. Patients can choose to take it with or after a meal, which will not affect the absorption of the drug. After a patient has been on treatment for at least 4 weeks, if their condition remains stable and the drug is tolerated well, the doctor may consider adjusting the dose to 10 mg twice daily. Furthermore, if the patient's condition still has room for improvement after a treatment regimen of 10 mg twice a day for at least 4 weeks, and the drug is still well tolerated, the doctor may continue to adjust the dose to the maximum recommended dose of 15 mg twice a day.

For special groups, such as patients with liver impairment, the dose for patients with moderate liver impairment should not exceed 10 mg twice daily; while patients with severe liver impairment should avoid the use of benzalantamine. For patients with renal impairment, the dose needs to be adjusted according to the creatinine clearance. For patients with a creatinine clearance of 9 to 59 ml/min, the dose should generally not exceed 10 mg twice a day. For patients with a creatinine clearance of less than 9 ml/min, use is not recommended.

In addition, when taking benzalantamine, patients should swallow the tablet whole and do not split, crush or chew it to avoid damaging its sustained-release structure and affecting the therapeutic effect. During treatment, patients need to maintain adequate fluid intake, but they should not be taken with alcohol as this may affect efficacy or increase side effects.

In summary, benzalantamine is an effective drug for the treatment of mild to moderate dementia in Alzheimer's disease. When using it, patients need to strictly follow the doctor's advice, pay attention to usage and dosage, and pay close attention to their own reactions and tolerance. Doctors should also formulate and adjust individualized treatment plans based on the patient's specific conditions to ensure the safety and effectiveness of the treatment.

Reference link:https://www.drugs.com/pro/zunveyl.html#S12.3